193 related articles for article (PubMed ID: 19508713)
1. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Zhuang PY; Liang Y; Tan YS; He J
BMC Cancer; 2009 Jun; 9():176. PubMed ID: 19508713
[TBL] [Abstract][Full Text] [Related]
2. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; He J; Zeng HY; Chang JY
Mol Biol Rep; 2012 Feb; 39(2):2021-9. PubMed ID: 21647551
[TBL] [Abstract][Full Text] [Related]
3. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome.
Xiang Z; Zeng Z; Tang Z; Fan J; Sun H; Wu W; Tan Y
Cancer J; 2009; 15(6):519-25. PubMed ID: 20010172
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
8. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
[TBL] [Abstract][Full Text] [Related]
10. Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma.
Zhao FL; Guo W
Mol Biol Rep; 2011 Feb; 38(2):1039-45. PubMed ID: 20563655
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma.
Wu X; Zhang L; Zhou J; Liu L; Fu Q; Fu A; Feng X; Xin R; Liu H; Gao Y; Xue J
Curr Probl Cancer; 2019 Feb; 43(1):18-26. PubMed ID: 29776595
[TBL] [Abstract][Full Text] [Related]
12. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.
Schimanski CC; Bahre R; Gockel I; Müller A; Frerichs K; Hörner V; Teufel A; Simiantonaki N; Biesterfeld S; Wehler T; Schuler M; Achenbach T; Junginger T; Galle PR; Moehler M
Br J Cancer; 2006 Jul; 95(2):210-7. PubMed ID: 16819541
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Kim J; Mori T; Chen SL; Amersi FF; Martinez SR; Kuo C; Turner RR; Ye X; Bilchik AJ; Morton DL; Hoon DS
Ann Surg; 2006 Jul; 244(1):113-20. PubMed ID: 16794396
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
[TBL] [Abstract][Full Text] [Related]
15. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
16. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
17. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
18. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.
Yang J; Zhang L; Jiang Z; Ge C; Zhao F; Jiang J; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
Theranostics; 2019; 9(20):5810-5827. PubMed ID: 31534521
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 expression in early breast cancer and risk of distant recurrence.
Andre F; Xia W; Conforti R; Wei Y; Boulet T; Tomasic G; Spielmann M; Zoubir M; Berrada N; Arriagada R; Hortobagyi GN; Hung MC; Pusztai L; Delaloge S; Michiels S; Cristofanilli M
Oncologist; 2009 Dec; 14(12):1182-8. PubMed ID: 19939894
[TBL] [Abstract][Full Text] [Related]
20. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
